Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Phosphorylation N S25 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Phosphorylation N S25 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Phosphorylation N S25 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Methylation N R27 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Methylation N R27 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Methylation N R27 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Phosphorylation N S28 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Phosphorylation N S28 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Phosphorylation N S28 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Acetylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Acetylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Acetylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Methylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Liver cancer Methylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Methylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Methylation N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Ubiquitination N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Ubiquitination N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Ubiquitination N K29 P16949 3925 STMN1 C1orf215 LAP18 OP18 Brain cancer Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Colorectal cancer Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Malignant glioma Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Melanoma Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Ovarian adenocarcinoma Phosphorylation N S31 P16949 3925 STMN1 C1orf215 LAP18 OP18 Medulloblastoma Phosphorylation N S38 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Ubiquitination N K41 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Ubiquitination N K43 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Phosphorylation N S46 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Acetylation N K52 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Acetylation N K52 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Ubiquitination N K52 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Ubiquitination N K52 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Acetylation N K53 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Acetylation N K53 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Ubiquitination N K53 P16949 3925 STMN1 C1orf215 LAP18 OP18 Skin cutaneous melanoma Ubiquitination N K53 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Ubiquitination N K62 P16949 3925 STMN1 C1orf215 LAP18 OP18 Sarcoma Ubiquitination N K62 P16949 3925 STMN1 C1orf215 LAP18 OP18 Stomach adenocarcinoma Ubiquitination N K62 P16949 3925 STMN1 C1orf215 LAP18 OP18 Blastoma Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Kidney renal papillary cell carcinoma Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Liver cancer Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Sarcoma Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Stomach adenocarcinoma Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Stomach cancer Phosphorylation N S63 P16949 3925 STMN1 C1orf215 LAP18 OP18 Sarcoma Acetylation N K70 P16949 3925 STMN1 C1orf215 LAP18 OP18 Sarcoma Ubiquitination N K70 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hematologic cancer Acetylation N K119 P16949 3925 STMN1 C1orf215 LAP18 OP18 Uterine corpus endometrial carcinoma Phosphorylation N T146 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma O-linked glycosylation N S2 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome O-linked glycosylation N S2 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia O-linked glycosylation N S2 P46527 1027 CDKN1B KIP1 p27 Non-Hodgkin's lymphoma O-linked glycosylation N S2 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma O-linked glycosylation N S2 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma Phosphorylation N S10 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S10 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S10 P46527 1027 CDKN1B KIP1 p27 Non-Hodgkin's lymphoma Phosphorylation N S10 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma Phosphorylation N S10 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation C S12 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma Phosphorylation N S12 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S12 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S12 P46527 1027 CDKN1B KIP1 p27 Non-Hodgkin's lymphoma Phosphorylation N S12 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma Phosphorylation N S12 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma Ubiquitination N K25 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K25 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K25 P46527 1027 CDKN1B KIP1 p27 Colon adenocarcinoma Ubiquitination N K68 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K68 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K68 P46527 1027 CDKN1B KIP1 p27 Breast cancer Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Colon adenocarcinoma Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Colorectal cancer Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N Y74 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma Ubiquitination N K81 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K81 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K81 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma Phosphorylation C S83 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S83 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S83 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma Phosphorylation N Y88 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N Y88 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N Y88 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N Y89 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N Y89 P46527 1027 CDKN1B KIP1 p27 Stomach adenocarcinoma Phosphorylation N Y89 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome O-linked glycosylation N S106 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia O-linked glycosylation N S106 P46527 1027 CDKN1B KIP1 p27 Non-Hodgkin's lymphoma O-linked glycosylation N S106 P46527 1027 CDKN1B KIP1 p27 Hepatocellular carcinoma O-linked glycosylation N S110 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome O-linked glycosylation N S110 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia O-linked glycosylation N S110 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K134 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K134 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation C S140 P46527 1027 CDKN1B KIP1 p27 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S140 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S140 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S140 P46527 1027 CDKN1B KIP1 p27 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K153 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K153 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K153 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma O-linked glycosylation N T157 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome O-linked glycosylation N T157 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia O-linked glycosylation N T157 P46527 1027 CDKN1B KIP1 p27 Pancreatic adenocarcinoma O-linked glycosylation N T157 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma O-linked glycosylation N T157 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma Phosphorylation N T157 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N T157 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N T157 P46527 1027 CDKN1B KIP1 p27 Pancreatic adenocarcinoma Phosphorylation N T157 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma Phosphorylation N T157 P46527 1027 CDKN1B KIP1 p27 Bladder urothelial carcinoma Ubiquitination N K165 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Ubiquitination N K165 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Ubiquitination N K165 P46527 1027 CDKN1B KIP1 p27 Pancreatic adenocarcinoma Ubiquitination N K165 P46527 1027 CDKN1B KIP1 p27 Transitional cell carcinoma Ubiquitination N K165 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S175 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S175 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N S178 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N S178 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N T187 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N T187 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome O-linked glycosylation N T198 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia O-linked glycosylation N T198 P46527 1027 CDKN1B KIP1 p27 Hereditary cancer-predisposing syndrome Phosphorylation N T198 P46527 1027 CDKN1B KIP1 p27 Multiple endocrine neoplasia Phosphorylation N T198 P98160 3339 HSPG2 Brain lower grade glioma O-linked glycosylation N T42 P98160 3339 HSPG2 Lung adenocarcinoma O-linked glycosylation N T269 P98160 3339 HSPG2 Kidney renal papillary cell carcinoma O-linked glycosylation N S279 P98160 3339 HSPG2 Breast invasive carcinoma Phosphorylation N S472 P98160 3339 HSPG2 Lung adenocarcinoma N-linked glycosylation N N555 P98160 3339 HSPG2 Colon adenocarcinoma Ubiquitination N K1002 P98160 3339 HSPG2 Lung adenocarcinoma Phosphorylation N T2006 P98160 3339 HSPG2 Ovarian adenocarcinoma Phosphorylation N Y2024 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma Phosphorylation N Y2024 P98160 3339 HSPG2 Breast invasive carcinoma Phosphorylation N S2113 P98160 3339 HSPG2 Lung adenocarcinoma O-linked glycosylation N T2139 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma O-linked glycosylation N T2139 P98160 3339 HSPG2 Lung adenocarcinoma O-linked glycosylation N S2141 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma O-linked glycosylation N S2141 P98160 3339 HSPG2 Colon adenocarcinoma O-linked glycosylation N T2146 P98160 3339 HSPG2 Lung adenocarcinoma O-linked glycosylation N T2146 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma O-linked glycosylation N T2146 P98160 3339 HSPG2 Colon adenocarcinoma O-linked glycosylation N S2151 P98160 3339 HSPG2 Colon adenocarcinoma O-linked glycosylation N T2152 P98160 3339 HSPG2 Brain lower grade glioma Phosphorylation N S2403 P98160 3339 HSPG2 Breast invasive carcinoma Phosphorylation N S2403 P98160 3339 HSPG2 Glioblastoma multiforme O-linked glycosylation N S2530 P98160 3339 HSPG2 Lung squamous cell carcinoma O-linked glycosylation N S2530 P98160 3339 HSPG2 Glioblastoma multiforme Phosphorylation N T2844 P98160 3339 HSPG2 Glioblastoma multiforme O-linked glycosylation N S3413 P98160 3339 HSPG2 Microcephaly O-linked glycosylation N S3413 P98160 3339 HSPG2 Skin cutaneous melanoma N-linked glycosylation N N3781 P98160 3339 HSPG2 Glioblastoma multiforme N-linked glycosylation N N3837 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma N-linked glycosylation N N3837 P98160 3339 HSPG2 Stomach adenocarcinoma N-linked glycosylation N N4069 P98160 3339 HSPG2 Brain lower grade glioma Phosphorylation N S4307 P98160 3339 HSPG2 Colon adenocarcinoma Phosphorylation N S4307 P98160 3339 HSPG2 Uterine corpus endometrial carcinoma Phosphorylation N S4307 P46527 1027 CDKN1B KIP1 p27 T-cell acute lymphoblastic leukemia T-ALL cell lines Polyubiquitination U 34407842 P46527 1027 CDKN1B KIP1 p27 Hepatocellular carcinoma tumor tissue Ubiquitination U 33589597 P46527 1027 CDKN1B KIP1 p27 Acute myeloid leukemia tumor tissue Ubiquitination U 29209041 P46527 1027 CDKN1B KIP1 p27 Breast cancer BC tissues and cell lines Ubiquitination U 35813480 P46527 1027 CDKN1B KIP1 p27 Glioblastoma glioma tissues Ubiquitination U 36792756 P16949 3925 STMN1 C1orf215 LAP18 OP18 Triple-negative breast cancer TNBC tissues Deubiquitination U 36484700 P16949 3925 STMN1 C1orf215 LAP18 OP18 Renal cell carcinoma RCC tissues Ubiquitination D 37054771 P16949 3925 STMN1 C1orf215 LAP18 OP18 Colorectal cancer CRC tissues Serine phosphorylation U S16 36221072 P46527 1027 CDKN1B KIP1 p27 Gallbladder carcinoma SGC-996 cells Serine phosphorylation U S10 33444777 P46527 1027 CDKN1B KIP1 p27 Head and neck squamous cell carcinoma tumor tissue Tyrosine phosphorylation U Y88 35247157 P46527 1027 CDKN1B KIP1 p27 T-cell acute lymphoblastic leukemia T-ALL cell lines Threonine phosphorylation U T187 34407842 P16949 3925 STMN1 C1orf215 LAP18 OP18 Alzheimer's disease Serine phosphorylation D S25 16925597 P16949 3925 STMN1 C1orf215 LAP18 OP18 Schizophrenia Serine phosphorylation U S25 16925597 P16949 3925 STMN1 C1orf215 LAP18 OP18 Alzheimer's disease Serine phosphorylation D S38 16925597 P16949 3925 STMN1 C1orf215 LAP18 OP18 Schizophrenia Serine phosphorylation U S38 16925597 P98160 3339 HSPG2 Gallbladder carcinoma GBC cells Sulfation U 27502167 P16949 3925 STMN1 C1orf215 LAP18 OP18 Breast cancer/tumor/carcinoma breast cancer cells Serine phosphorylation D S16 21768358 P16949 3925 STMN1 C1orf215 LAP18 OP18 Endometrial cancer/carcinoma tumor tissue Serine phosphorylation P S38 23538402 P46527 1027 CDKN1B KIP1 p27 Breast cancer/tumor/carcinoma MCF7 Serine phosphorylation P S10 21067268;21216562 P46527 1027 CDKN1B KIP1 p27 Ovarian cancer/carcinoma SKOV-3 cell line Threonine phosphorylation P T157 23339869 P46527 1027 CDKN1B KIP1 p27 Oral squamous cell carcinoma cell line Threonine phosphorylation U T157 23106397 P46527 1027 CDKN1B KIP1 p27 Breast cancer/tumor/carcinoma MCF7 cell line Threonine phosphorylation P T187 23769441 P46527 1027 CDKN1B KIP1 p27 Lymphoma lymphoma cells Threonine phosphorylation U T187 22492278 P46527 1027 CDKN1B KIP1 p27 Melanoma cell line Threonine phosphorylation P T198 19470470 P46527 1027 CDKN1B KIP1 p27 Corticotroph tumor Phosphorylation U 12050228 P16949 3925 STMN1 C1orf215 LAP18 OP18 Gallbladder carcinoma Acetylation U K9 35581193 P16949 3925 STMN1 C1orf215 LAP18 OP18 Fanconi anemia Serine phosphorylation D S16 26466335 P16949 3925 STMN1 C1orf215 LAP18 OP18 Breast cancer Serine phosphorylation U S16 26087399 P16949 3925 STMN1 C1orf215 LAP18 OP18 Hepatocellular carcinoma/hepatocarcinoma/hepatoma Serine phosphorylation P S25 26505358 P16949 3925 STMN1 C1orf215 LAP18 OP18 Breast cancer Serine phosphorylation U S25 26087399 P16949 3925 STMN1 C1orf215 LAP18 OP18 Fanconi anemia Serine phosphorylation D S38 26466335 P16949 3925 STMN1 C1orf215 LAP18 OP18 Breast cancer Serine phosphorylation U S38 26087399;27130664 P16949 3925 STMN1 C1orf215 LAP18 OP18 Breast cancer Serine phosphorylation U S63 26087399 P46527 1027 CDKN1B KIP1 p27 Atherosclerosis Serine phosphorylation P S10 21885849 P46527 1027 CDKN1B KIP1 p27 Epithelial ovarian cancer Serine phosphorylation P S10 24018641 P46527 1027 CDKN1B KIP1 p27 Breast cancer Serine phosphorylation U S10 25205104 P46527 1027 CDKN1B KIP1 p27 Chronic myelogenous leukemia/chronic myeloid leukemia Serine phosphorylation U S10 24098519 P46527 1027 CDKN1B KIP1 p27 Non-alcoholic steatohepatitis Serine phosphorylation U S10 24351862 P46527 1027 CDKN1B KIP1 p27 Breast cancer/tumor/carcinoma Tyrosine phosphorylation U Y74 17254967 P46527 1027 CDKN1B KIP1 p27 Leukemia Tyrosine phosphorylation A Y88 35597806 P46527 1027 CDKN1B KIP1 p27 Breast cancer/tumor/carcinoma Threonine phosphorylation D T157 26701207 P46527 1027 CDKN1B KIP1 p27 Renal cancer/carcinoma Threonine phosphorylation D T157 19118035 P46527 1027 CDKN1B KIP1 p27 Renal cancer/carcinoma Threonine phosphorylation U T157 19118035 P46527 1027 CDKN1B KIP1 p27 Thyroid cancer/carcinoma Threonine phosphorylation U T157 15743786 P46527 1027 CDKN1B KIP1 p27 B-cell lymphoma Threonine phosphorylation U T187 21338280 P46527 1027 CDKN1B KIP1 p27 Hepatocellular carcinoma Threonine phosphorylation U T187 33574916 P46527 1027 CDKN1B KIP1 p27 Prostate cancer/carcinoma/adenocarcinoma Threonine phosphorylation U T187 23707764 P46527 1027 CDKN1B KIP1 p27 Renal cancer/carcinoma Threonine phosphorylation D T198 19118035 P46527 1027 CDKN1B KIP1 p27 Renal cancer/carcinoma Threonine phosphorylation U T198 19118035 P46527 1027 CDKN1B KIP1 p27 Thyroid cancer/carcinoma Threonine phosphorylation U T198 15743786